Top Page
Fevertree Drinks
(LSE:FEVR)
Fevertree Drinks (FEVR) vs. iShares MSCI United Kingdom ETF (EWC)
Fevertree Drinks Business Overview & Revenue Model
Fevertree Drinks Earnings Call Summary
Fevertree Drinks Financial Statement Overview
| Breakdown | ||||
| Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 368.50M | 364.40M | 344.30M | 311.10M | 252.10M | Gross Profit |
| 138.40M | 109.00M | 118.80M | 130.90M | 116.30M | EBIT |
| 32.80M | 20.80M | 30.60M | 55.60M | 51.30M | EBITDA |
| 45.70M | 30.80M | 37.20M | 60.60M | 55.60M | Net Income Common Stockholders |
| 24.40M | 15.40M | 24.90M | 44.60M | 41.70M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 96.00M | 59.90M | 95.30M | 166.20M | 143.10M | Total Assets |
| 321.90M | 313.70M | 311.60M | 336.10M | 298.40M | Total Debt |
| 12.10M | 15.20M | 16.90M | 2.90M | 1.90M | Net Debt |
| -83.90M | -44.70M | -78.40M | -163.30M | -141.20M | Total Liabilities |
| 75.20M | 75.90M | 72.40M | 54.50M | 45.80M | Stockholders Equity |
| 246.70M | 237.80M | 239.20M | 281.60M | 252.60M |
| Cash Flow | Free Cash Flow | |||
| 56.10M | -13.40M | 1.40M | 42.20M | 35.50M | Operating Cash Flow |
| 70.20M | -3.80M | 8.50M | 46.80M | 38.10M | Investing Cash Flow |
| -10.80M | -9.60M | -10.00M | -4.30M | -3.80M | Financing Cash Flow |
| -23.60M | -23.10M | -70.70M | -19.30M | -19.60M |
Fevertree Drinks Technical Analysis
Fevertree Drinks Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £1.72B | 14.01 | 9.02% | 0.86% | 5.90% | 11.24% | |
77 Outperform | £752.04M | 18.88 | 13.01% | 4.07% | 5.10% | 3.23% | |
77 Outperform | $1.10B | 43.11 | 10.23% | 2.45% | 1.13% | 58.33% | |
76 Outperform | £14.34B | 20.69 | 26.05% | 1.87% | 2.77% | 26.43% | |
73 Outperform | £515.52M | 28.87 | 19.67% | 0.02% | 1.21% | -2.98% | |
65 Neutral | $8.82B | 14.91 | 4.71% | 6.22% | 3.60% | -2.66% | |
56 Neutral | £617.08M | 55.25 | 2.40% | 3.61% | -2.68% | -511.88% |
Fevertree Drinks Corporate Events
Fevertree Drinks PLC announced the repurchase of 31,034 ordinary shares as part of its buyback program, initially announced in February 2025. The shares were purchased at prices ranging from 894 to 907 pence and will be canceled, potentially impacting the company’s stock value and shareholder equity.
The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.
Fever-Tree announced that David Lapp, a Non-Executive Director, purchased 24,590 ordinary shares in the company at an average price of USD 12.28 per share via the US OTC Markets. This transaction highlights the confidence of the company’s management in its market position and future prospects, potentially impacting stakeholder perceptions positively.
The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.
Fevertree Drinks PLC has repurchased 56,428 of its own ordinary shares at prices ranging from 880.00 to 903.00 pence per share, with a weighted average price of 891.9747 pence. The company plans to cancel these shares as part of a buyback program announced in February 2025, which may impact the company’s stock value and shareholder equity by reducing the number of shares in circulation.
The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.
Fevertree Drinks PLC announced the repurchase of 57,187 of its ordinary shares at a weighted average price of 899.9966 pence per share, with the intention to cancel these shares. This buyback, part of a previously announced program, is aimed at optimizing the company’s capital structure and potentially enhancing shareholder value.
The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.
Fevertree Drinks PLC has executed a share buyback, purchasing 60,000 ordinary shares at prices ranging from 873.00 to 893.00 pence, with a weighted average price of 883.0958 pence. This move, part of a previously announced buyback program, aims to cancel the purchased shares, potentially impacting the company’s stock value and signaling confidence in its financial health.
The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.
Fevertree Drinks PLC announced the repurchase of 34,128 ordinary shares as part of its ongoing buyback program. This move, conducted through Investec Bank plc, reflects the company’s strategy to manage its capital structure and potentially enhance shareholder value by reducing the number of shares in circulation.
The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.
Fevertree Drinks PLC announced the repurchase of 16,394 ordinary shares as part of a buyback program initiated in February 2025. The shares were acquired at prices ranging from 867 to 887 pence and will be canceled, reflecting the company’s strategy to enhance shareholder value and optimize its capital structure.
The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.
Fevertree Drinks PLC has announced a share buyback, purchasing 40,682 ordinary shares at prices ranging from 873 to 890 pence per share, with a weighted average price of 883.4405 pence. This move, part of a previously announced buyback program, aims to enhance shareholder value and reflects the company’s strategic focus on optimizing its capital structure.
The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.
Fever-Tree announced that all resolutions were passed at its Annual General Meeting, indicating strong shareholder support and potentially reinforcing its market position as a leading supplier in the premium mixers industry. This outcome may positively impact the company’s operations and reassure stakeholders of its strategic direction.
The most recent analyst rating on (GB:FEVR) stock is a Buy with a £11.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.
Fevertree Drinks PLC has repurchased 26,202 of its own ordinary shares at a weighted average price of 885.4531 pence per share. This move is part of a buyback program announced earlier in the year, aimed at reducing the number of shares in circulation, which could potentially enhance shareholder value by increasing earnings per share.
The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.
Fever-Tree reports steady trading performance, with significant progress in the US market following a strategic partnership with Molson Coors. The company maintains its leading position in the UK and shows growth in Europe, despite muted sales in Germany. Fever-Tree has initiated local production in Australia to support brand momentum. A recent 10% tariff on UK imports to the US will be shared with Molson Coors, with plans to mitigate its impact through on-shored production. The company is also executing a share buyback program, reflecting a strong balance sheet and focus on cash flow generation.
The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.
Fever-Tree Drinks plc has announced a trading update ahead of its Annual General Meeting, highlighting its strategic partnership with Molson Coors in the US, which is expected to drive significant growth. The company maintains its strong market position in the UK and Europe, with local production beginning in Australia to support market share growth. Fever-Tree is also managing the impact of a new 10% tariff on UK imports into the US through shared costs with Molson Coors and plans for on-shored US production. The company has initiated a share buyback program, reflecting its strong balance sheet and cash flow prospects, and remains focused on investment opportunities and potential M&A activities.
The most recent analyst rating on (GB:FEVR) stock is a Hold with a £8.60 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.
Fevertree Drinks PLC has announced a change in major holdings, with The Capital Group Companies, Inc. increasing its voting rights to 5.144183%. This acquisition of voting rights signifies a strategic move by The Capital Group, potentially impacting Fevertree’s future decisions and influencing its market positioning. The shares are managed under the discretionary investment management of Capital Group’s affiliates, indicating a strong institutional interest in Fevertree’s operations.
The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.
Fevertree Drinks PLC announced the repurchase of 56,611 of its ordinary shares, as part of a buyback program initiated in February 2025. The shares were bought at prices ranging from 856.00 to 880.00 pence and will be canceled, which may positively impact the company’s stock value by reducing the number of shares in circulation, potentially enhancing shareholder value.
The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.
Fevertree Drinks PLC announced the repurchase of 57,570 ordinary shares as part of its ongoing buyback program, with the intention to cancel these shares. This move aligns with the company’s strategy to manage its capital structure and potentially enhance shareholder value, reflecting a proactive approach in its financial management.
The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.
Fevertree Drinks plc announced that its total issued share capital consists of 122,277,559 ordinary shares, each with one voting right, resulting in the same number of total voting rights. This information is crucial for shareholders to determine their interest in the company under the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.
Fevertree Drinks PLC has announced the repurchase of 35,613 of its ordinary shares as part of a buyback program initiated in February 2025. The shares were bought at prices ranging from 874 to 885 pence and will be canceled, which could potentially enhance shareholder value by reducing the number of shares outstanding.
The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.
Fevertree Drinks PLC announced the purchase of 48,008 ordinary shares as part of its share buyback program, with the intention to cancel these shares. This move, executed through Investec Bank, reflects the company’s strategy to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.
Fevertree Drinks PLC announced the repurchase of 60,000 of its ordinary shares, as part of a buyback program initiated earlier in the year. The shares were bought at prices ranging from 860 to 883 pence and will be canceled, potentially enhancing shareholder value by reducing the number of shares outstanding.
The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.
Fevertree Drinks PLC announced the repurchase of 37,797 of its ordinary shares, with prices ranging between 860.00 and 880.00 pence per share, as part of a buyback program initiated earlier in the year. This move, conducted through Investec Bank, is intended to cancel the repurchased shares, potentially impacting the company’s stock value and shareholder equity by reducing the number of shares in circulation.
The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.
Fevertree Drinks PLC has announced the repurchase of 49,792 ordinary shares as part of its share buyback program, with plans to cancel the purchased shares. This move, executed through Investec Bank, is part of a broader strategy to enhance shareholder value and optimize the company’s capital structure.
The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.
Fevertree Drinks PLC has executed a share buyback, purchasing 60,000 ordinary shares at prices ranging from 871.00 to 905.00 pence, with a weighted average price of 896.1786 pence. This move, part of a previously announced buyback program, aims to cancel the purchased shares, potentially enhancing shareholder value and reflecting confidence in the company’s financial health.
The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.
Fevertree Drinks PLC has announced the repurchase of 54,917 ordinary shares as part of its ongoing buyback program, with prices ranging from 875 to 887 pence per share. This strategic move, authorized by shareholders, is intended to enhance shareholder value by reducing the number of outstanding shares, potentially improving earnings per share and signaling confidence in the company’s future prospects.
The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.
Fevertree Drinks PLC has executed a share buyback program, purchasing 59,878 ordinary shares at prices ranging from 859 to 887 pence per share, with a weighted average price of 880.5816 pence. This move, authorized by shareholders, is part of a strategic initiative announced earlier in February 2025, and the company plans to cancel the repurchased shares, potentially impacting its market positioning and shareholder value.
The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.
Fevertree Drinks plc has announced the grant of options over 380,286 ordinary shares to its Executive Directors under the Long Term Incentive Plan. The options, issued to CEO Tim Warrillow and CFO Andy Branchflower, are set to vest in 2028, contingent on performance conditions from 2025 to 2027. This move aligns with the company’s strategy to incentivize leadership and potentially strengthen its market position.
The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.
Fevertree Drinks PLC has announced a share buyback program, purchasing 32,043 ordinary shares at a weighted average price of 860.9356 pence per share. This move, authorized by shareholders, is part of a broader strategy to manage the company’s capital structure and potentially enhance shareholder value by reducing the number of shares in circulation.
The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.
Fevertree Drinks PLC has announced the purchase of 56,861 ordinary shares as part of its share buyback program, authorized during the 2024 Annual General Meeting. The shares were bought at prices ranging from 854 to 886 pence and will be canceled, which is expected to enhance shareholder value and optimize the company’s capital structure.
The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.
Fevertree Drinks PLC has executed a share buyback, purchasing 53,866 ordinary shares at a weighted average price of 864.1817 pence per share. This move, part of a previously announced buyback program, aims to cancel the purchased shares, potentially enhancing shareholder value and signaling confidence in the company’s financial health.
The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.
Fevertree Drinks PLC has announced the purchase of 58,769 ordinary shares as part of a buyback program authorized by shareholders at the 2024 Annual General Meeting. The shares were bought at prices ranging from 843.00 to 858.00 pence, with a weighted average price of 853.3752 pence. This move is part of a strategic initiative to manage the company’s capital structure, potentially enhancing shareholder value by reducing the number of shares in circulation.
The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.
Fevertree Drinks PLC has executed a share buyback program, purchasing 59,733 ordinary shares at a weighted average price of 857.9776 pence per share. This move, authorized by shareholders, is part of a broader strategy announced in February 2025, aimed at optimizing the company’s capital structure by canceling the purchased shares, potentially enhancing shareholder value and signaling confidence in the company’s future performance.
The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.
Fevertree Drinks PLC has announced the purchase of 41,654 ordinary shares as part of its share buyback program, which was authorized by shareholders in 2024. The shares were acquired at prices ranging from 841 to 864 pence and will be canceled, reflecting the company’s strategy to enhance shareholder value and optimize its capital structure.
The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.
Fevertree Drinks PLC has announced the repurchase of 44,166 of its ordinary shares as part of a buyback program initiated earlier in the year. The shares were bought at prices ranging from 828.00 to 848.00 pence, with a weighted average price of 834.6532 pence, and the company plans to cancel these shares. This move is likely aimed at enhancing shareholder value and optimizing the company’s capital structure.
Fevertree Drinks PLC announced a share buyback transaction, purchasing 49,348 ordinary shares at a weighted average price of 822.0948 pence per share. This move, part of a previously announced buyback program, aims to cancel the purchased shares, potentially impacting the company’s stock value and shareholder equity.
Fevertree Drinks PLC announced the repurchase of 52,993 of its ordinary shares as part of a buyback program initiated in February 2025. The shares were bought at prices ranging from 802.00 to 818.00 pence, with a weighted average price of 809.1636 pence. This move is part of the company’s strategy to enhance shareholder value by reducing the number of shares in circulation, potentially increasing earnings per share and signaling confidence in the company’s financial health.
Fevertree Drinks PLC announced the repurchase of 54,162 ordinary shares, as part of a buyback program initiated in February 2025, with plans to cancel these shares. This move is likely aimed at enhancing shareholder value and optimizing the company’s capital structure, potentially impacting its market positioning positively.
Fevertree Drinks PLC has announced a buyback of 40,994 of its ordinary shares, executed through its broker, Investec Bank plc. The shares were purchased at prices ranging from 815.00 to 822.00 pence, with a weighted average price of 819.5199 pence. The company plans to cancel these shares, which is part of a buyback program initiated in February 2025. This move may impact the company’s share value and is a strategic decision to manage its capital structure, potentially benefiting shareholders by increasing earnings per share.
Fevertree Drinks PLC has announced the repurchase of 21,275 ordinary shares as part of its ongoing buyback program. The shares were purchased at a weighted average price of 810.3865 pence per share and will be canceled, reflecting the company’s strategy to manage its capital structure and potentially enhance shareholder value.
Fevertree Drinks PLC announced the repurchase of 60,000 ordinary shares as part of its ongoing buyback program, with plans to cancel the purchased shares. This strategic move, executed through Investec Bank, is aimed at enhancing shareholder value and reflects the company’s confidence in its financial position, potentially impacting its stock performance and market perception positively.
Fevertree Drinks PLC has announced the repurchase of 60,000 of its ordinary shares at a weighted average price of 794.9749 pence per share. This buyback is part of a previously announced program and the company intends to cancel the purchased shares, which could potentially enhance shareholder value by reducing the number of shares outstanding.
Fevertree Drinks PLC announced the repurchase of 56,489 ordinary shares as part of its ongoing buyback program, with plans to cancel these shares. This move, executed through Investec Bank, reflects the company’s strategy to manage its capital structure and could potentially enhance shareholder value by reducing the number of shares outstanding.
Fevertree Drinks PLC announced the repurchase of 59,806 ordinary shares as part of its share buyback program, with the intention to cancel these shares. This move is part of a strategy to enhance shareholder value and optimize the company’s capital structure, potentially impacting its stock performance and market perception positively.
Fevertree Drinks plc has executed a share buyback, purchasing 60,000 ordinary shares at prices ranging from 762 to 780 pence, with a weighted average price of 768.1231 pence. This move, part of a previously announced buyback program, aims to cancel the purchased shares, potentially impacting the company’s share value and signaling confidence in its financial health.
Fever-Tree has released its 2024 Annual Report and announced the date for its Annual General Meeting, which will be held on June 5, 2025. This announcement is significant for stakeholders as it provides insights into the company’s financial performance and strategic direction, reinforcing its position as a leader in the premium mixers market.
Fevertree Drinks PLC announced the purchase of 115,242 ordinary shares as part of its share buyback program, with plans to cancel these shares. This move is part of a broader strategy to optimize capital structure and potentially enhance shareholder value, reflecting the company’s proactive approach in managing its financial resources.
Fevertree Drinks PLC has announced the repurchase of 118,562 of its ordinary shares as part of a buyback program initiated in February 2025. The shares were bought at prices ranging from 774 to 790 pence and will be canceled, potentially impacting the company’s share value and signaling confidence in its financial health.
Fevertree Drinks PLC has announced a change in the breakdown of its voting rights, with Lindsell Train Limited increasing its stake to 11.00% from the previous 10.66%. This adjustment in voting rights could potentially influence the company’s strategic decisions and reflects Lindsell Train’s confidence in Fevertree’s market position.
Fevertree Drinks PLC has announced the repurchase of 102,070 ordinary shares as part of its ongoing buyback program, with the intention to cancel these shares. This move, executed through Investec Bank, reflects the company’s strategy to manage its capital structure and potentially enhance shareholder value by reducing the number of shares outstanding.
Fevertree Drinks PLC has announced the repurchase of 119,118 ordinary shares as part of its buyback program, with the intention to cancel these shares. This move, facilitated by Investec Bank PLC, is part of a broader strategy to enhance shareholder value and optimize the company’s capital structure, potentially impacting its market positioning and stakeholder interests.
Fevertree Drinks PLC has announced the repurchase of 115,554 ordinary shares as part of its ongoing buyback program, with the intention to cancel these shares. This move, executed through Investec Bank plc, reflects the company’s strategy to enhance shareholder value and optimize its capital structure, potentially impacting its market positioning and investor relations.
Fevertree Drinks PLC announced the repurchase of 100,617 of its ordinary shares as part of a buyback program initiated in February 2025. The shares were bought at prices ranging from 781 to 787 pence per share, with the company planning to cancel these shares. This move is part of Fevertree’s strategy to manage its share capital effectively, potentially enhancing shareholder value and signaling confidence in its financial health.
Fevertree Drinks PLC announced the purchase of 111,021 ordinary shares as part of its share buyback program, with the intention to cancel the acquired shares. This move, executed through Investec Bank, reflects the company’s strategy to manage its capital structure and potentially enhance shareholder value, indicating a proactive approach in maintaining its market position.
Fever-Tree Drinks PLC has announced the extension of its share buyback program by £29 million, bringing the total to £100 million. The extension, facilitated by Investec Bank, will continue until the end of 2025, allowing the company to repurchase ordinary shares under pre-set parameters, potentially impacting its market positioning and shareholder value.
Fever-Tree has announced an extension of its share buyback program, increasing the total to £100 million, with the extension running until the end of 2025. This move, facilitated by Investec Bank, aims to repurchase ordinary shares, reflecting the company’s strategic financial management and potentially impacting its market positioning and shareholder value.
Fevertree Drinks PLC announced the repurchase of 118,647 ordinary shares as part of its ongoing buyback program, with the intention to cancel these shares. This move, executed through Investec Bank, reflects the company’s strategy to manage its capital structure and potentially enhance shareholder value.
Fevertree Drinks PLC has executed a share buyback program, purchasing 99,817 ordinary shares at prices ranging from 731.00 to 762.00 pence, with a weighted average price of 745.2936 pence. This move, authorized by shareholders, aims to cancel the acquired shares, potentially enhancing shareholder value and reflecting confidence in the company’s financial health.
Fevertree Drinks PLC announced the repurchase of 101,033 ordinary shares as part of its ongoing buyback program, with the intention to cancel these shares. This move, executed through Investec Bank, reflects the company’s strategy to manage its capital structure and potentially enhance shareholder value by reducing the number of shares outstanding.
Fevertree Drinks PLC has announced the repurchase of 114,587 of its ordinary shares, as part of a buyback program initiated in February 2025. The shares were purchased at prices ranging from 746 to 802 pence per share, with a weighted average price of 774.4085 pence. The company intends to cancel these shares, a move that could potentially enhance shareholder value by reducing the number of shares outstanding, thereby increasing earnings per share and potentially improving the stock’s market performance.
Fevertree Drinks PLC announced a buyback of 110,957 ordinary shares, executed through Investec Bank plc, with plans to cancel these shares. This move, part of a previously announced buyback program, is likely aimed at consolidating the company’s share capital, potentially enhancing shareholder value and signaling confidence in the company’s financial health.
Fevertree Drinks PLC announced a share buyback transaction, purchasing 92,436 ordinary shares at prices ranging from 790 to 816 pence per share. This move is part of a previously announced buyback program aimed at enhancing shareholder value by reducing the number of outstanding shares, which could potentially improve earnings per share and market perception.
Fevertree Drinks PLC announced the repurchase of 92,436 ordinary shares as part of its buyback program, with plans to cancel these shares. This move is part of a strategic initiative to optimize the company’s capital structure, potentially enhancing shareholder value and signaling confidence in its financial health.
Fevertree Drinks PLC has executed a share buyback program, purchasing 116,458 ordinary shares at prices ranging from 797 to 824 pence per share, with a weighted average price of 813.0240 pence. This move, authorized by shareholders at the 2024 Annual General Meeting, is part of a broader buyback initiative announced in February 2025, and the company plans to cancel the purchased shares, potentially impacting its stock value and shareholder equity.
Fevertree Drinks PLC has announced the repurchase of 112,965 ordinary shares as part of its ongoing share buyback program, with plans to cancel the acquired shares. This move, executed through Investec Bank, reflects the company’s strategy to enhance shareholder value and optimize its capital structure, potentially impacting its market positioning and investor relations.
Fevertree Drinks PLC announced its total voting rights, with the company’s issued share capital comprising 125,286,080 ordinary shares, each carrying one voting right. This information is crucial for shareholders for regulatory compliance under the FCA’s Disclosure Guidance and Transparency Rules, impacting how they manage their interests in the company.
Fevertree Drinks PLC has executed a share buyback program, purchasing 40,844 ordinary shares at prices ranging from 793.50 to 806.00 pence per share, with a weighted average price of 798.6542 pence. This move, authorized by shareholders, aims to cancel the purchased shares, potentially impacting the company’s stock value and signaling confidence in its financial health.
Fevertree Drinks PLC has announced a share buyback, purchasing 52,909 ordinary shares at prices ranging from 783.00 to 795.50 pence per share. This move, part of a previously announced buyback program, aims to reduce the number of shares in circulation, potentially increasing the value of remaining shares and reflecting confidence in the company’s financial health.
Fevertree Drinks PLC announced the repurchase of 6,962 ordinary shares as part of its ongoing buyback program, with the intention to cancel these shares. This move, executed through Investec Bank, reflects the company’s strategy to enhance shareholder value and optimize its capital structure, potentially impacting its market positioning and stakeholder interests.
Fevertree Drinks PLC announced the repurchase of 105,284 of its ordinary shares as part of a buyback program initiated in February 2025. The shares were purchased at prices ranging from 728.50 to 754.50 pence and will be canceled, indicating a strategic move to enhance shareholder value and optimize the company’s capital structure.
Fevertree Drinks PLC reported a 4% revenue growth for FY24, driven by strong performance in the US and an improved gross margin. The company announced a strategic partnership with Molson Coors to enhance its growth in the US, granting Molson Coors exclusive rights for sales, distribution, and production, while Fevertree retains brand control. This partnership aims to leverage Molson Coors’ extensive network to boost Fevertree’s market presence and operational efficiency, marking a significant step in Fevertree’s expansion strategy.
Fevertree Drinks PLC has repurchased 98,039 of its ordinary shares as part of a buyback program announced earlier this year. The shares were acquired at prices ranging from 726.00 to 739.50 pence and will be canceled, potentially enhancing shareholder value by reducing the total number of shares outstanding. This move is part of Fever-Tree’s strategy to manage its capital structure and could positively impact its market positioning by signaling confidence in the company’s financial health.
Fevertree Drinks PLC has announced the repurchase of 50,341 ordinary shares as part of its buyback program, with the intention to cancel these shares. This move, executed through Investec Bank plc, reflects the company’s strategy to manage its capital structure and potentially enhance shareholder value by reducing the number of shares in circulation.
Fevertree Drinks PLC has announced the repurchase of 77,148 ordinary shares as part of its ongoing share buyback program, initially announced in February 2025. This move, executed through Investec Bank, reflects the company’s strategy to manage its capital structure and potentially enhance shareholder value by reducing the number of shares outstanding.
Fevertree Drinks PLC announced the purchase of 66,392 of its own ordinary shares, with the intention to cancel them, as part of a buyback program initiated in February 2025. This move is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value, reflecting a proactive approach in maintaining its market position.
Fevertree Drinks PLC has announced the purchase of 66,392 of its own ordinary shares, as part of a buyback program initiated in February 2025. The shares were bought at prices ranging from 707 to 741 pence and will be canceled, potentially enhancing shareholder value by reducing the number of shares in circulation.
Fevertree Drinks PLC has announced the repurchase of 110,854 ordinary shares as part of its ongoing share buyback program, initially announced in February 2025. The repurchased shares, acquired at prices ranging from 697.00 to 720.50 pence, are intended to be canceled, which could potentially enhance shareholder value by reducing the total number of shares outstanding.
Fevertree Drinks PLC has announced the repurchase of 118,647 of its ordinary shares, as part of a buyback program initiated in February 2025. The shares were bought at prices ranging between 695.00 and 715.00 pence, with a weighted average price of 707.3902 pence. The company plans to cancel these shares, which could potentially enhance shareholder value by reducing the number of shares outstanding, thereby increasing the earnings per share. This move reflects Fevertree’s strategic focus on optimizing its capital structure and delivering value to its stakeholders.